Moleculin Biotech is trading 7.38% up at $0.70, supported primarily by biotech-sector strength, with XBI up 2.75% during regular trading.
- No new company-specific announcement dated September 2, 2026, was identified.
- The latest listed release was its August 27 investor-conference participation.
- Prior trial and financing updates remain background catalysts, not confirmed explanations for this move.